Zealand Pharma A/S
ZLDPF
$65.16
$1.802.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.82% | -462.54% | 9.51% | -19.33% | 21.51% |
| Total Depreciation and Amortization | -0.88% | 48.78% | -47.72% | 1,811.55% | -- |
| Total Amortization of Deferred Charges | 1,264.45% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -177.01% | -29.50% | -64.26% | -66.21% | 161.03% |
| Change in Net Operating Assets | -49.60% | 90.72% | 84.63% | 88.44% | 624.92% |
| Cash from Operations | -400.20% | -164.41% | -29.94% | -14.93% | 122.20% |
| Capital Expenditure | 82.67% | 69.62% | -95.79% | -219.52% | -5.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,020.96% | -3,907.07% | 97.90% | -2,080.27% | -87.40% |
| Cash from Investing | 2,128.12% | -3,927.10% | 97.49% | -2,048.20% | -93.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.85% | -55.74% | 99.28% | -28.19% | -148.46% |
| Issuance of Common Stock | -99.45% | -23.99% | 366.44% | 4,358.01% | -98.17% |
| Repurchase of Common Stock | -- | -- | -94.78% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.91% | -- | -196.08% | -- | 98.51% |
| Cash from Financing | -181.44% | -6,913.23% | 667.93% | 6,003.98% | -99.23% |
| Foreign Exchange rate Adjustments | 151.65% | -137.49% | -24.22% | 153.90% | 64.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -146.87% | -11,912.59% | 1,371.79% | 194.66% | -87.97% |